Buy tech sell-off, Wedbush’s Ives says: ’this is a 1996 moment, not 1999’
Richard Buchholz, Chief Financial Officer of Inspire Medical Systems, Inc. (NASDAQ:INSP), sold 11,000 shares of common stock on August 29, 2025, for $93.39, totaling approximately $1027290. The sale comes amid a challenging period for the stock, which has declined nearly 48% over the past six months. According to InvestingPro data, 12 analysts have recently revised their earnings expectations downward for the upcoming period.
Following the transaction, Buchholz directly owns 44,867 shares of Inspire Medical Systems.
Additionally, Buchholz indirectly owns 1,475 shares each through his daughter and three sons.
In other recent news, Inspire Medical Systems has announced several significant developments. The company has initiated a $200 million stock buyback program, which will run through August 7, 2027, unless altered by the Board. This decision comes alongside the announcement that Chief Financial Officer Rick Buchholz will step down from his position effective December 31, 2025, with plans to remain in an advisory role until February 28, 2026. Meanwhile, Evercore ISI has initiated coverage on Inspire Medical Systems with an Outperform rating, citing the company’s strong growth outlook and high gross margins. Jefferies has adjusted its price target for the company from $205 to $160 while maintaining a Buy rating, noting a second-quarter sales beat but slower progress on the Inspire 5 rollout. Additionally, KeyBanc continues to maintain a Sector Weight rating on the stock. These developments highlight the company’s strategic financial maneuvers and analyst perspectives on its future trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.